Emerging Programs for Autism Spectrum Disorder: Improving Communication, Behavior, and Family Dynamics brings forward a hybrid and a transdisciplinary methodology to identify methods used to diagnose, treat, and manage those with autism within personal and social constructs and values building exemplary international experiences from across the globe. Luminary experts offer their superb level of expertise through their research, experience, and clinical work. The book addresses all the aspects of care, lifespan, and lifestyle issues from treatment to living. It will emphasize issues related to neurodiversity, individuality, best practices, and support of people on the Autism Spectrum and their families. In addition, this book includes specific case studies, highlighting family experiences and the application of best practices by therapists thereof.
Dr. Neophytos (Neo) L. Papaneophytou earned a Ph.D. in Clinical Psychology and holds licenses to practice psychotherapy in various States in America. He has completed specialization training in the areas of sexual abuse and maltreatment, personality disorders and trauma. Dr. Papaneophytou has extensive experience working with both victims and abusers. Moreover, he as experience diagnosing and treating various psychiatric conditions and stressors related to anxiety, mood disorders, depression, schizophrenia, bereavement, divorce, adjustment issues, LGBTQU issues, ADHD, PTSD, school/behavioral issues, and parenting among others. When working with clients (children, adults, and couples) Dr. Papaneophytou utilizes a client-centered approach to facilitate optimal therapeutic results that allows clients to enjoy an improved quality of life. In his client-centered approach, Dr. Papaneophytou utilizes techniques from the following therapeutic orientations: cognitive behavioral therapy, dialectical behavioral therapy, transference-focused psychotherapy, dynamic psychotherapy, and trauma-focused CBT. In addition to his clinical practice and research, Dr. Papaneophytou’s career has included over 20 years of the teaching of multiple graduate and undergraduate psychology courses at institutions such as the City University of New York, The State University of New York, and many other local and international universities. Dr. Papaneophytou is the founder and President of non-profit organizations, aiming at expanding awareness and offering actionable help to people on the Autism Spectrum and their families. He organized the Annual Cyprus International Conference on Autism Treatment and Research, and he is working toward the establishment of a model Center for Excellence: The Cyprus International Center for Autism Education Treatment and Research. This is the 3
rd book Dr. Papaneophytou has co-authored pertinent to ASD. He welcomes scientific collaboration, particularly comparative international research.
Undurti N. Das is an M.D. in Internal Medicine from Osmania Medical College, Hyderabad, India; a Fellow of the National Academy of Medical Sciences, India, and Shanti Swaroop Bhatnagar prize awardee. Apart from clinical work, he is researching the role of polyunsaturated fatty acids, cytokines, nitric oxide, free radicals, and anti-oxidants in cancer, inflammation, metabolic syndrome, schizophrenia, sepsis, rheumatological conditions and autisms. His current interests include the epidemiological and molecular aspects of autism, diabetes mellitus, hypertension, cardiovascular diseases and metabolic syndrome. Dr. Das was formerly scientist at Efamol Research Institute, Kentville, Canada; Professor of Medicine at Nizam’s Institute of Medical Sciences, Hyderabad, India and Research Professor of Surgery and Nutrition at SUNY (State University of New York) Upstate Medical University, Syracuse, USA. At present, he is the Chairman and Research Director of UND Life Sciences LLC, USA, and serves as a consultant to both Indian and USA based biotech and pharmaceutical companies. Undurti Das is the Founding Editor of the international journal: Lipids in Health and Disease; and serves on the editorial board of another 10 international journals. Dr Das has more than 500 international publications and has been awarded 5 USA patents.
